|
AmerisourceBergen
(COR)
|
12.1 |
$38M |
|
282k |
135.33 |
|
Apellis Pharmaceuticals Put Option
(APLS)
|
11.0 |
$35M |
|
508k |
68.30 |
|
GSK Sponsored Ads
(GSK)
|
7.4 |
$23M |
|
791k |
29.43 |
|
Medicus Sciences Acquisition Cl A Shs
|
7.3 |
$23M |
|
2.3M |
9.90 |
|
Relmada Therapeutics Put Option
(RLMD)
|
7.1 |
$22M |
|
606k |
37.02 |
|
Prometheus Biosciences Put Option
|
6.2 |
$20M |
|
332k |
59.01 |
|
Bicycle Therapeutics Sponsored Ads
(BCYC)
|
5.1 |
$16M |
|
683k |
23.26 |
|
Organon & Co Common Stock
(OGN)
|
4.7 |
$15M |
|
629k |
23.40 |
|
Cigna Corp
(CI)
|
4.6 |
$15M |
|
53k |
277.47 |
|
Sanofi Sa Sponsored Adr
(SNY)
|
4.3 |
$14M |
|
357k |
38.02 |
|
Inogen
(INGN)
|
4.0 |
$13M |
|
521k |
24.28 |
|
Centene Corporation
(CNC)
|
3.1 |
$9.9M |
|
127k |
77.81 |
|
United Therapeutics Corporation
(UTHR)
|
3.0 |
$9.4M |
|
45k |
209.39 |
|
The Beauty Health Com Cl A
(SKIN)
|
2.5 |
$7.8M |
|
659k |
11.79 |
|
Smith & Nephew Spdn Adr New
(SNN)
|
1.7 |
$5.3M |
|
228k |
23.22 |
|
Vanda Pharmaceuticals
(VNDA)
|
1.5 |
$4.8M |
|
489k |
9.88 |
|
Point Biopharma Global
|
1.3 |
$4.2M |
|
545k |
7.73 |
|
Inari Medical Ord
|
1.3 |
$4.2M |
|
58k |
72.63 |
|
Universal Health Services CL B
(UHS)
|
1.1 |
$3.6M |
|
41k |
88.18 |
|
Eucrates Biomedical Acquisition Corp. Unit 10/23/2027
|
0.8 |
$2.5M |
|
249k |
10.02 |
|
Health Sciences Acquisitions Corp 2 Ord Shs
|
0.8 |
$2.5M |
|
250k |
9.90 |
|
Aeglea Biotherapeutics
|
0.8 |
$2.5M |
|
4.7M |
0.53 |
|
X4 Pharmaceuticals
|
0.8 |
$2.4M |
|
1.4M |
1.71 |
|
Modular Medical Com New
(MODD)
|
0.8 |
$2.4M |
|
574k |
4.12 |
|
Cymabay Therapeutics
|
0.6 |
$1.9M |
|
556k |
3.50 |
|
Bausch Health Companies Put Option
(BHC)
|
0.6 |
$1.9M |
|
281k |
6.89 |
|
Renovacor
|
0.6 |
$1.9M |
|
736k |
2.52 |
|
Merus N V
(MRUS)
|
0.6 |
$1.8M |
|
88k |
20.03 |
|
Affimed Therapeutics B V
|
0.5 |
$1.7M |
|
821k |
2.06 |
|
Iveric Bio Put Option
|
0.5 |
$1.5M |
|
86k |
17.94 |
|
Tyra Biosciences
(TYRA)
|
0.4 |
$1.3M |
|
152k |
8.79 |
|
Savara
(SVRA)
|
0.4 |
$1.3M |
|
856k |
1.55 |
|
Biosante Pharmaceuticals
(ANIP)
|
0.4 |
$1.3M |
|
40k |
32.15 |
|
Moleculin Biotech
|
0.3 |
$1.1M |
|
1.0M |
1.06 |
|
Ideaya Biosciences
(IDYA)
|
0.3 |
$1.0M |
|
70k |
14.91 |
|
Fusion Pharmaceuticals
|
0.2 |
$784k |
|
260k |
3.01 |
|
Connect Biopharma Holdings Ads
(CNTB)
|
0.2 |
$771k |
|
598k |
1.29 |
|
Aslan Pharmaceuticals Ads
|
0.2 |
$761k |
|
1.3M |
0.60 |
|
Elevation Oncology
(ELEV)
|
0.1 |
$406k |
|
360k |
1.13 |
|
Nextcure
(NXTC)
|
0.1 |
$358k |
|
130k |
2.75 |
|
Caremax Com Cl A
|
0.1 |
$218k |
|
31k |
7.09 |
|
Vincerx Pharma Com New
|
0.0 |
$141k |
|
102k |
1.38 |
|
Neubase Therapeutics Ord
|
0.0 |
$102k |
|
259k |
0.39 |
|
Nyxoah Sa SHS
(NYXH)
|
0.0 |
$101k |
|
16k |
6.27 |
|
Clene Common Stock Put Option
|
0.0 |
$64k |
|
23k |
2.82 |
|
Humacyte *w Exp 09/21/202
(HUMAW)
|
0.0 |
$58k |
|
50k |
1.16 |
|
Renovacor *w Exp 99/99/999
|
0.0 |
$37k |
|
400k |
0.09 |
|
Neoleukin Therapeutics
|
0.0 |
$25k |
|
38k |
0.65 |
|
Caremax *w Exp 06/08/202
|
0.0 |
$23k |
|
13k |
1.80 |